COVID-19: NAFDAC Says Nigeria To Start Local Vaccine Production

Chinyere Ogbo

The National Agency for Food and Drug Administration and Control, NAFDAC, has revealed that Nigeria is ready to commence local manufacture of COVID-19 vaccines.

Director General, DG, of youth he Agency, Prof. Mojishola Adeyeye, while addressing the media on Monday, November 22, 2021, disclosed that the inability of the country to manufacture COVID-19 vaccines locally was due to the absence of regulatory capacity to guide and maintain requisite standards in the vaccine production venture.

According to the DG,  Nigeria has made significant improvements in meeting the conditions set by the World Health Organization (WHO); especially for the manufacturing of COVID-19 vaccines; adding that the agency has successfully met 368 recommendations given by the world health body.

“This journey started in January, 2018…WHO gave us 868 recommendations to meet before being recognised for maturity level three. We have been on that journey and it is good to share this audience that as at October 15, 2021; we have no other recommendation to meet, So, from 868 to nil, that is where we are.

‘’Nigeria is now closer to manufacturing our vaccines locally and it will no longer be because of the regulatory agency,” she said.

The Agency said that part of the requirement is that it has to expand and equip its drug and vaccine laboratories in Yaba and Oshodi to attain the specified standards; noting that attaining the global benchmark in laboratory facility was a key requirement for proper regulation of vaccine manufacturing.

She said the WHO would be sending a team to verify and certify the laboratories.

Add Comment